Home Search Abstracts View Session Email Abstract Author


Session 8-Oral Abstracts
HIV Prevention: HSV-2, Topical and Oral PrEP, and Circumcision
Monday, 10 am-12:15 pm; Ballroom A
Paper # 36
Longer-term Effects of Male Circumcision on HIV Incidence and Risk Behaviors during Post-trial Surveillance in Rakai, Uganda
Xiangrong Kong*1, G Kigozi2, V Ssempija2, D Serwadda2,3, F Nalugoda2, F Makumbi2,3, T Lutalo2, S Watya2,3, M Wawer1,2, and R Gray1,2
1Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; 2Rakai Hlth Sci Prgm, Entebbe, Uganda; and 3Makerere Univ, Kampala, Uganda

Background:  Three trials demonstrate the efficacy of male circumcision for HIV prevention over 2 years, but longer-term effectiveness and impact on risk behaviors are unknown.

Methods:  A randomized trial of male circumcision enrolled 4996 HIV men aged 15 to 49 in Rakai, Uganda. Following trial closure for efficacy, we offered male circumcision to control participants and maintained post-trial surveillance of intervention and control arm men up to 2.28 years. HIV incidence per 100 person-years was assessed by an as-treated analysis. Sociodemographic and sexual risk characteristics of controls opting for or declining male circumcision, and within-individual changes in behaviors (∆) were assessed during the first post-trial follow-up using Wilcoxon rank test or linear models for repeated categorical responses.

Results:  Of control arm participants, 80.4% accepted male circumcision. During ~2.28 years of post-trial surveillance, overall HIV incidence was 0.54/100 person-years in circumcised men and 1.66/100 person-years in uncircumcised men (effectiveness 67%, 95%CI 41 to 82%). Post-trial HIV incidence was 0.55/100 person-years in circumcised men. In analyses restricted to control arm participants during post-trial surveillance, HIV incidence was 0.53/100 person-years in circumcised controls and 1.65/100 person-years in uncircumcised controls (effectiveness 68%, 95%CI 35 to 85%). Controls accepting or declining circumcision were comparable in age, education, marital status, number of sex partners, and condom and alcohol use with sex. During the post-trial follow-up, both groups reported no change in number of non-marital sex partners, decreased alcohol use with sex (∆ –9.3%, p <0.001), decreased consistent (∆ –4.3%, p <0.001), and any condom use(∆ –6.2%, p <0.001). However, the risk behavior changes were not statistically different between circumcised (n = 1321) and uncircumcised (n = 372) men.

Conclusions:  The effectiveness of male circumcision during a post-trial observational study was comparable to the efficacy of circumcision for HIV prevention during a randomized trial. Post-trial male circumcision acceptance was high among controls, with no evidence of self-selection. Condom use declined in controls both opting for and declining male circumcision, however, the changes were similar between groups and there was no evidence of risk compensation associated with circumcision.